Skip to content

Adenomyosis in Fertile Women in MUSA Criteria

Application of the Revised Morphological Uterus Sonographic Assessment (MUSA) Criteria to Diagnose Adenomyosis in Fertile Women

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06250569
Enrollment
144
Registered
2024-02-09
Start date
2024-02-29
Completion date
2025-07-31
Last updated
2024-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenomyosis

Brief summary

1. To estimate the prevalence of adenomyosis in fertile women aged 18-30 years using the revised MUSA ultrasound criteria. 2. To evaluate clinical risk factors that are associated with adenomyosis diagnosis in this population

Detailed description

Adenomyosis is a benign condition characterized by the presence endometrial glands and stroma within the myometrium. Its prevalence varies from 5-70%. The definitive diagnosis of adenomyosis is based mainly on histological assessment of hysterectomy specimens. This led to a concept that adenomyosis affects only parous women between 35-50 years who complain of dysmenorrhea and heavy menstrual bleeding. Magnetic Resonance Imaging (MRI) can detect adenomyosis with a sensitivity of 80%. Transvaginal ultrasound using the revised Morphological Uterus Sonographic Assessment (MUSA) criteria can detect adenomyosis non-invasively at a lower cost. Such advancements in imaging techniques allow studying the prevalence of the disease in wider range of population including young women.

Interventions

None listed

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* women with regular menstrual cycle attending outpatient clinic for contraception counseling * age 18 -30 years old

Exclusion criteria

* Women on hormonal contraception * Infertile women * Associated pathologies like endometriosis, uterine fibroids. and ovarian cysts

Design outcomes

Primary

MeasureTime frameDescription
adenomyosis in fertile women1.5 yearEstimation of the prevalence of adenomyosis diagnosed using revised MUSA criteria among fertile women aged 18-30 years.

Countries

Egypt

Contacts

Primary ContactAya Nour elzanaty, MBBch
Aya.elzanaty214@gmail.com01022739886
Backup ContactEssam Rashad, Prof
essamothman@aun.edu.eg01001330534

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026